Eagle Meds Services
HERNEXEOS (zongertinib)
Available to sourceHuman Prescription DrugOncology & Specialty

HERNEXEOS (zongertinib)

60 mg/1 · Film-Coated Tablet
By Boehringer Ingelheim Pharmaceuticals, Inc.
NDC
0597-9257
Route
Oral
Therapeutic class
Breast Cancer Resistance Protein Inhibitors [MoA], HER2/Neu/cerbB2 Antagonists [MoA], Kinase Inhibitor
Marketing category
NDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
HERNEXEOS (zongertinib)
NDC 0597-9257
(980) 480-3410 requests@eaglemedsservices.com

Related in Oncology & Specialty

See all →
Verzenio (abemaciclib)

Verzenio (abemaciclib)

50 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

200 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

100 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

150 mg/1 · Tablet
Eli Lilly and Company
Available to source